HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lanford, R. E. Articles by White, A. L. Search for Related Content PubMed PubMed Citation Articles by Lanford, R. E. Articles by White, A. L. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 2055-2064, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Neomycin inhibits secretion of apolipoprotein[a] by increasing retention on the hepatocyte cell surface

RE Lanford, L Estlack and AL White
Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA.

Neomycin therapy reduces plasma levels of low density lipoprotein and lipoprotein[a] (Lp[a]). To determine whether neomycin directly alters the biogenesis of Lp[a], we have examined the effect of neomycin on apolipoprotein[a] (apo[a]) synthesis and secretion in primary cultures of baboon hepatocytes. Using this system, we have previously shown that apo[a] is synthesized as a lower molecular weight precursor that upon maturation becomes associated with the cell surface before release into the culture medium. Treatment of hepatocytes with 10 mM neomycin reduced levels of apo[a] in the culture medium by as much as 12-fold. Although a portion of the reduced secretion could be accounted for by a reduction in total protein synthesis, the greatest effect of neomycin on apo[a] secretion was to decrease the release of mature apo[a] from the hepatocyte cell surface into the culture medium. Treatment of hepatocyte cultures with trypsin confirmed that mature apo[a] in neomycin-treated cells was still transported to the cell surface. Examination of related antibiotics demonstrated that inhibition of apo[a] secretion is a general property shared by the deoxystreptamine antibiotics. The mechanism by which neomycin affects the apo[a]-cell surface interaction is not known, but neomycin is known to perturb cell surface membranes, inhibit the interaction of some ligands with their cell surface receptors, and inhibit the metabolism of phosphatidylinositol 4,5 biphosphate. These studies suggest that cell surface association of apo[a] may play a role in Lp[a] biogenesis in vivo.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. H. Lane, B. Dvorak, N. K. MacLennan, K. Dvorakova, M. D. Halpern, T. D. Pham, and A. F. Philipps IGF alters jejunal glucose transporter expression and serum glucose levels in immature rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1450 - R1460. [Abstract] [Full Text] [PDF]

				R. E. Lanford, D. Chavez, B. Guerra, J. Y. N. Lau, Z. Hong, K. M. Brasky, and B. Beames Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes J. Virol., September 1, 2001; 75(17): 8074 - 8081. [Abstract] [Full Text] [PDF]

				J. Wang, J. Boedeker, H. H. Hobbs, and A. L. White Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures J. Lipid Res., January 1, 2001; 42(1): 60 - 69. [Abstract] [Full Text]

				K. Nilausen and H. Meinertz Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein Am. J. Clinical Nutrition, March 1, 1999; 69(3): 419 - 425. [Abstract] [Full Text] [PDF]

				A. L. White, B. Guerra, J. Wang, and R. E. Lanford Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway J. Lipid Res., February 1, 1999; 40(2): 275 - 286. [Abstract] [Full Text]